The Christie Paterson Cancer Research Centre
Following a devastating fire which caused significant damage to the Paterson cancer research facility in 2017, building work on the new Paterson building at The Christie NHS Foundation Trust in Manchester has completed.
The building is part of the Manchester Cancer Research Centre – a highly successful partnership between three powerhouses of innovation, The Christie, Cancer Research UK and The University of Manchester – and will be one of the top cancer research centres in the world.
Integrated Health Projects (IHP), the joint venture between VINCI Building and Sir Robert McAlpine and its supply chain partners, BDP, Arup and Imtech have realised a fantastic, state-of-the-art facility that will lead world-class transformational cancer research.
The building is set to become home to the largest concentration of scientists, doctors, and nurses in Europe. 300 scientists and 400 clinicians and operational staff, practicing what is known as ‘team science’, will deliver clinical trials covering the full extent of the patient pathway, from prevention and novel treatments to living with and beyond cancer.
Shortlisted for a 2024 RICS North West award in the public sector category, at more than 25,000 square metres and ten storeys high, the building is more than twice the size of the previous facility, allowing experts to deliver discovery research and translate their findings into innovative clinical trials, at scale.
The building will be occupied by all three of the partners. It’ll be home to the Cancer Research UK Manchester Institute, as well as several other teams from The University of Manchester’s Division of Cancer Sciences. It will also be Manchester’s scientific headquarters for discovery science within the international Alliance for Early Cancer Detection.
A central component of the building is the new Cancer Research UK Cancer Biomarker Centre. The centre’s focus will be on biomarkers to aid in early cancer detection and diagnosis, and enable personalised management of a patient’s cancer, to determine which therapy will bring the most benefit.
Professor Dame Nancy Rothwell, President and Vice-Chancellor of The University of Manchester, comments: “The new research building will be a fantastic opportunity to accelerate cancer research in Manchester, not just because it will provide state-of-the-art facilities, but because it will bring together a fantastic workforce comprised of scientists, clinicians, and support staff, including trainees, early career researchers and world-renowned investigators. It will enable staff from The University’s Division of Cancer Sciences to work side-by-side with colleagues from the Cancer Research UK Manchester Institute and The Christie, generating new ideas, making new discoveries, and devising next-generation therapies.
“Together with the Proton Beam Therapy Centre and the Oglesby Cancer Research Building, the new facility will be the latest piece of the cancer campus jigsaw, generating a vibrant, high-quality environment for our highly motivated research teams, all seeking to improve the lives of cancer patients, not just in Manchester but world-wide.”
Ged Couser, Architect Principal at BDP, said: “This building adds a striking new addition to the Manchester skyline, delivering a technologically advanced structure that is already raising the profile of academic collaboration and R&D in the North of England. This project is a prime example of what can be achieved with the right planning, funding, and design to create effective, beautiful, highly specialised places that impact positively on communities, businesses and local people.
“We are so proud to have worked on the new Christie Paterson and to be witnessing these moments as the building becomes occupied. It shows that great design can create flexible spaces which centre on diagnoses, patient care, and vital, world-leading research in a truly collaborative environment; about which, we are so excited.

